Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for ...
BOCA RATON, Fla. - Entero Therapeutics, Inc. (NASDAQ:ENTO), a clinical-stage biopharmaceutical company with a market capitalization of $2.45 million, today announced the appointment of Richard Paolone ...
Diabetes patients may experience certain symptoms of stomach pain and not know what the cause for it is. Here are 10 possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback